{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:17:42Z","timestamp":1780575462914,"version":"3.54.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015789","name":"Dalian High-Level Talent Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017683","name":"Dalian Science and Technology Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Aims:<\/jats:bold> Reports of hepatitis in children during the coronavirus disease 2019 (COVID-19) pandemic garnered worldwide attention. The most probable culprits are adenovirus and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). At present, the optimal symptomatic treatment consists of a combination of anti-COVID-19 and hepatitis symptom alleviators. Schisandrin B (SchB) has been known to have liver-protective properties for a long time, whereas anti-COVID-19 properties only recently have been discovered. In the case of COVID-19 with hepatitis of unknown origin, we used network pharmacology to explore the symptomatic therapy and protective effects of SchB.<\/jats:p><jats:p><jats:bold>Main methods:<\/jats:bold> The most probable protein targets of SchB were predicted in the SwissTargetPrediction database. The GeneCards, National Center for Biotechnology Information, and Online Mendelian Inheritance in Man databases were used to compile information on the diseases hepatitis, adenovirus, and SARS-CoV-2. Following the use of a Venn diagram viewer to identify intersection genes, we constructed a protein\u2013protein interaction network and identified the core genes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment, as well as molecular docking, were employed to highlight the mechanisms of SchB on hepatitis.<\/jats:p><jats:p><jats:bold>Key findings:<\/jats:bold> SchB contains 27 targets on adenovirus_hepatitis and 16 targets on SARS-CoV-2_hepatitis, with 12 shared genes. Both target populations clustered in viral infection and cancer pathways, as well as in processes such as kinase activity phosphatase, cell adhesion, and ATPase binding. These genes might be closely related to liver damage and membrane binding from adenovirus or SARS-CoV-2 infections. In addition, epidermal growth factor receptor, HSP90AA1, and MAPK1 were among the top five targets of both SchB SARS-CoV-2 hepatitis and SchB adenovirus hepatitis.<\/jats:p><jats:p><jats:bold>Significance:<\/jats:bold> SchB may target common protective targets and mechanisms against acute hepatitis caused by adenovirus or by SARS-CoV-2 in children during the COVID-19 pandemic. These findings indicate SchB\u2019s potential as a treatment for hepatitis of unknown origin.<\/jats:p>","DOI":"10.3389\/fphar.2022.969709","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T05:57:57Z","timestamp":1660197477000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yanhua","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/MPG.0000000000003404","article-title":"Severe hepatitis in pediatric coronavirus disease 2019.","volume":"74","author":"Antala","year":"2022","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.15585\/mmwr.mm7118e1","article-title":"Acute hepatitis and adenovirus infection among children - Alabama, october 2021-february 2022.","volume":"71","author":"Baker","year":"2022","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinforma."},{"key":"B5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/s2468-1253(22)00166-2","article-title":"Severe acute hepatitis in children: Investigate SARS-CoV-2 superantigens","volume":"7","author":"Brodin","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/v14020353","article-title":"Screening of botanical drugs against SARS-CoV-2 entry reveals novel therapeutic agents to treat COVID-19","volume":"14","author":"Cao","year":"","journal-title":"Viruses"},{"key":"B7","doi-asserted-by":"publisher","first-page":"793888","DOI":"10.3389\/fphar.2022.793888","article-title":"Uncovering the pharmacological mechanisms of gexia-zhuyu formula (GXZY) in treating liver cirrhosis by an integrative pharmacology strategy","volume":"13","author":"Cao","year":"","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.15585\/mmwr.mm7126e1","article-title":"Interim analysis of acute hepatitis of unknown etiology in children aged <10 Years - United States, october 2021-june 2022.","volume":"71","author":"Cates","year":"2022","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"873105","DOI":"10.3389\/fnut.2022.873105","article-title":"Impact of prolonged COVID-19 lockdown on body mass index, eating habits, and physical activity of university students in Bangladesh: A web-based cross-sectional study","volume":"9","author":"Hossain","year":"2022","journal-title":"Front. Nutr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"12638","DOI":"10.3390\/ijms222312638","article-title":"Natural bioactive molecules: An alternative approach to the treatment and control of COVID-19","volume":"22","author":"Islam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"103737","DOI":"10.1016\/j.amsu.2022.103737","article-title":"Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions","volume":"78","author":"Islam","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1248\/bpb.b15-01020","article-title":"Protective effect of gomisin N against endoplasmic reticulum stress-induced hepatic steatosis","volume":"39","author":"Jang","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"B14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/antiox10040620","article-title":"Antioxidant effects of Schisandra chinensis fruits and their active constituents","volume":"10","author":"Kopustinskiene","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6171658","DOI":"10.1155\/2016\/6171658","article-title":"Schisandrin B: A double-edged sword in nonalcoholic fatty liver disease","volume":"2016","author":"Leong","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/biof.1224","article-title":"Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo","volume":"41","author":"Leong","year":"2015","journal-title":"BioFactors Oxf. Engl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jgh.12425","article-title":"Schisandrin B attenuates acetaminophen-induced hepatic injury through heat-shock protein 27 and 70 in mice","volume":"29","author":"Li","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","article-title":"Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis","volume":"76","author":"Li","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/157340609787049316","article-title":"Bicyclol: A novel drug for treating chronic viral Hepatitis B and C","volume":"5","author":"Liu","year":"2009","journal-title":"Med. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00230","DOI":"10.1128\/jvi.00230-21","article-title":"Regulation of hepatitis B virus replication by cyclin docking motifs in core protein","volume":"95","author":"Liu","year":"2021","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2200318","DOI":"10.2807\/1560-7917.ES.2022.27.15.2200318","article-title":"Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022","volume":"27","author":"Marsh","year":"2022","journal-title":"Euro Surveill."},{"key":"B22","doi-asserted-by":"publisher","first-page":"106682","DOI":"10.1016\/j.ijsu.2022.106682","article-title":"Emerging cases of acute hepatitis of unknown origin in children amid the ongoing COVID-19 pandemic: Needs attention - Correspondence","volume":"102","author":"Mohapatra","year":"2022","journal-title":"Int. J. Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijid.2022.05.028","article-title":"High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children","volume":"122","author":"Nishiura","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"113041","DOI":"10.1016\/j.biopha.2022.113041","article-title":"Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology","volume":"150","author":"Rahman","year":"","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"113217","DOI":"10.1016\/j.biopha.2022.113217","article-title":"Exploring the plant-derived bioactive substances as antidiabetic agent: An extensive review","volume":"152","author":"Rahman","year":"","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/molecules27051713","article-title":"The multifunctional role of herbal products in the management of diabetes and obesity: A comprehensive review","volume":"27","author":"Rahman","year":"","journal-title":"Mol. (Basel, Switz."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1016\/j.fct.2009.09.003","article-title":"Schisandrin B stimulates a cytoprotective response in rat liver exposed to mercuric chloride","volume":"47","author":"Stacchiotti","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43856-021-00025-z","article-title":"Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series","volume":"1","author":"Wang","year":"2021","journal-title":"Commun. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"566348","DOI":"10.3389\/fmicb.2020.566348","article-title":"Influenza A virus induces autophagy by its hemagglutinin binding to cell surface heat shock protein 90AA1","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.3748\/wjg.v10.i20.2944","article-title":"Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells","volume":"10","author":"Wu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12275-015-4652-0","article-title":"From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors","volume":"53","author":"Xu","year":"2015","journal-title":"J. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"45171","DOI":"10.1038\/srep45171","article-title":"Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbrc.2016.11.164","article-title":"Protective effects of gomisin N against hepatic steatosis through AMPK activation","volume":"482","author":"Yun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1142\/s0192415x12500425","article-title":"Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo","volume":"40","author":"Zhu","year":"2012","journal-title":"Am. J. Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.969709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T05:58:00Z","timestamp":1660197480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.969709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":33,"alternative-id":["10.3389\/fphar.2022.969709"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.969709","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"article-number":"969709"}}